share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Apr 19 19:05
Summary by Moomoo AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 17, 2024. The transactions were executed in the open market with prices ranging from $103.0983 to $104.4896 per share, resulting in a total market value of approximately $1,550,703. After the sale, Afeyan directly holds 2,056,931 shares of Moderna. Additionally, Afeyan has an indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 17, 2024. The transactions were executed in the open market with prices ranging from $103.0983 to $104.4896 per share, resulting in a total market value of approximately $1,550,703. After the sale, Afeyan directly holds 2,056,931 shares of Moderna. Additionally, Afeyan has an indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more